Under the microscrope: Neuren Pharmaceuticals - John Pilcher, Chief Executive Officer
Senior Analyst Scott Power from the Morgans Healthcare team speaks with Jon Pilcher, Chief Executive Officer of Neuren Pharmaceuticals (ASX:NEU). Jon explains a number of key catalysts which are expected in 2021.
Under the microscrope: Neuren Pharmaceuticals - John Pilcher, Chief Executive Officer
Senior Analyst Scott Power from the Morgans Healthcare team speaks with Jon Pilcher, Chief Executive Officer of Neuren Pharmaceuticals (ASX:NEU). Jon explains a number of key catalysts which are expected in 2021.